BNP Paribas Financial Markets’s Picard Medical PMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$364 Sell
44
-3
-6% -$64 ﹤0.01% 5710
2026
Q1
$2.44K Buy
47
+7
+18% +$507 ﹤0.01% 5394
2025
Q4
$3.51K Buy
+40
New +$9.41K ﹤0.01% 5300

Other funds holding PMI

BNP Paribas Financial Markets's PMI Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Picard Medical (PMI) stake by 6.4% in Q2 2026, selling an estimated $64 and leaving 44 shares worth $364. The position accounts for ﹤0.01% of the portfolio, ranked #5710.

BNP Paribas Financial Markets first reported a position in PMI in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.51K in Q4 2025. 34 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

  • BNP Paribas Financial Markets held 44 shares of Picard Medical worth $364 as of Q2 2026.
  • BNP Paribas Financial Markets sold 3 Picard Medical shares in Q2 2026, an estimated $64.
  • Picard Medical made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5710 holding.
  • BNP Paribas Financial Markets first reported a position in Picard Medical in Q4 2025 and has held it in 3 quarters since.
  • BNP Paribas Financial Markets's Picard Medical position peaked at $3.51K in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.